Methods of modulating IL-23 activity; related reagents

Details for Australian Patent Application No. 2005215527 (hide)

Owner Schering Corporation

Inventors Katsikis, Peter D.; Cua, Daniel J.; Dimitriou, Ioannis

Agent Griffith Hack

Pub. Number AU-B-2005215527

PCT Pub. Number WO2005/079837

Priority 60/545,708 17.02.04 US

Filing date 15 February 2005

Wipo publication date 1 September 2005

Acceptance publication date 7 April 2011

International Classifications

C07K 14/54 (2006.01) Peptides having more than 20 amino acids

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 38/20 (2006.01) Medicinal preparations containing peptides - Interleukins

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

G01N 33/569 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

31 August 2006 PCT application entered the National Phase

  PCT publication WO2005/079837 Priority application(s): WO2005/079837

7 April 2011 Application Accepted

  Published as AU-B-2005215527

4 August 2011 Standard Patent Sealed

11 October 2012 Application for Amendment

  The nature of the amendment is: Amend the Patentee to read Merck Sharp & Dohme Corp. . Address for service in Australia - Griffith Hack Level 29, Northpoint 100 Miller Street North Sydney NSW 2060

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005215528-Use for interleukin-33 (IL33) and the IL33 receptor complex

2005215521-Treatment of abnormalities of the first metatarsophalangeal joint of the foot